Frankfurt - Delayed Quote EUR
KALA BIO, Inc. (27F0.F)
2.6940
+0.0820
+(3.14%)
As of 9:24:30 AM GMT+2. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 147.69k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BRAZZELL ROMULUS KIM Officer | Sale at price 7.63 per share. | Direct | 18,663 | Jan 6, 2025 |
| IWICKI MARK T. Chief Executive Officer | Sale at price 7.63 per share. | Direct | 44,094 | Jan 6, 2025 |
| BAZEMORE TODD M President | Sale at price 7.63 per share. | Direct | 15,207 | Jan 6, 2025 |
| REUMUTH MARY Chief Financial Officer | Sale at price 7.63 per share. | Direct | 13,017 | Jan 6, 2025 |
| KHARABI DARIUS Officer | Sale at price 7.63 per share. | Direct | 15,420 | Jan 6, 2025 |
| BRAZZELL ROMULUS KIM Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 6, 2025 |
| BRAZZELL ROMULUS KIM Officer | Stock Award(Grant) at price 0.00 - 7.63 per share. | Direct | 18,663 | Jan 6, 2025 |
| IWICKI MARK T. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 6, 2025 |
| BAZEMORE TODD M President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 6, 2025 |
| REUMUTH MARY Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 6, 2025 |
| KHARABI DARIUS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 6, 2025 |
| BAKER BROS ADVISORS, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.44 per share. | Indirect | 2,000,000 | Dec 30, 2024 |
| BRAZZELL ROMULUS KIM Officer | Sale at price 4.75 per share. | Direct | 26,073 | Jun 26, 2024 |
| IWICKI MARK T. Chief Executive Officer | Sale at price 4.75 per share. | Direct | 72,048 | Jun 26, 2024 |
| BAZEMORE TODD M President | Sale at price 4.75 per share. | Direct | 22,102 | Jun 26, 2024 |
| REUMUTH MARY Chief Financial Officer | Sale at price 4.75 per share. | Direct | 19,774 | Jun 26, 2024 |
| KHARABI DARIUS Officer | Sale at price 4.75 per share. | Direct | 24,500 | Jun 26, 2024 |
| BLUMENKRANZ MARK S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| PERRY GREGORY D Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| KOVEN ANDREW IAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| ROSEN HOWARD B Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| MYERS CHARLES DANIEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| FARID MARJAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
| BRAZZELL ROMULUS KIM Officer | Sale at price 6.09 per share. | Direct | 12,192 | May 31, 2024 |
| BAZEMORE TODD M President | Sale at price 6.09 per share. | Direct | 12,746 | May 31, 2024 |
| REUMUTH MARY Chief Financial Officer | Sale at price 6.09 per share. | Direct | 10,877 | May 31, 2024 |
| KHARABI DARIUS Officer | Sale at price 6.09 per share. | Direct | 1,407 | May 31, 2024 |
| BRAZZELL ROMULUS KIM Officer | Sale at price 6.74 per share. | Direct | 10,899 | Jan 4, 2024 |
| IWICKI MARK T. Chief Executive Officer | Sale at price 6.73 per share. | Direct | 30,547 | Jan 4, 2024 |
| BAZEMORE TODD M President | Sale at price 6.74 per share. | Direct | 9,470 | Jan 4, 2024 |
| TRACHTENBERG ERIC L. Officer | Sale at price 6.74 per share. | Direct | 8,270 | Jan 4, 2024 |
| REUMUTH MARY Chief Financial Officer | Sale at price 6.74 per share. | Direct | 8,270 | Jan 4, 2024 |
| KHARABI DARIUS Officer | Sale at price 6.73 per share. | Direct | 9,321 | Jan 4, 2024 |
| BRAZZELL ROMULUS KIM Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| IWICKI MARK T. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| BAZEMORE TODD M President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| TRACHTENBERG ERIC L. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| REUMUTH MARY Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| KHARABI DARIUS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| BLUMENKRANZ MARK S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 22, 2023 |
| PERRY GREGORY D Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 22, 2023 |
| KOVEN ANDREW IAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 22, 2023 |
| BRAZZELL ROMULUS KIM Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 22, 2023 |
| ROSEN HOWARD B Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 22, 2023 |
| IWICKI MARK T. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 22, 2023 |
| MYERS CHARLES DANIEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 22, 2023 |
| BAZEMORE TODD M President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 22, 2023 |
| TRACHTENBERG ERIC L. General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 22, 2023 |
| REUMUTH MARY Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 22, 2023 |
| KHARABI DARIUS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 22, 2023 |
Related Tickers
ONCT Oncternal Therapeutics, Inc.
0.5266
-24.12%
ACOG Alpha Cognition Inc.
4.8100
-2.15%
LPTX Leap Therapeutics, Inc.
0.3751
-5.03%
CRIS Curis, Inc.
1.4600
-2.67%
MREO Mereo BioPharma Group plc
2.5500
-0.39%
SWTX SpringWorks Therapeutics, Inc.
41.10
-0.27%
APVO Aptevo Therapeutics Inc.
0.6900
-6.76%
IOVA Iovance Biotherapeutics, Inc.
3.2750
+2.66%
VKTX Viking Therapeutics, Inc.
25.81
+0.06%